Search

Objective To analyze the research hotspot and trend of Traditional Chinese Medicine (TCM) nursing of post-stroke sleep disorders based on CiteSpace, and provide reference for clinical nursing and scientific research. Methods The literature on TCM nursing of sleep disorders after stroke published by CNKI, Wanfang, VIP and CBM databases from January 31, 2023 was retrieved. The annual number of publications, authors, research institutions, keyword co-occurrence, keyword clustering and keyword timeline were analyzed by CiteSpace software. Results A total of 177 literatures met the requirements were retrieved, and the overall number of publications was on the rise. The cooperation network between the authors and research institutions was not yet mature. The bibliometric results showed that research hotspots of literatures wereextended care, emotion care and TCM nursing technology. Conclusion TCM nursing intervention for sleep disorders after stroke has achieved good results, which can significantly improve the sleep quality of patients, promote the outcome of the disease, and improve the quality of life of patients. (目的 使用CiteSpace工具对卒中后睡眠障碍进行分析, 为今后的临床护理和相关研究提供一定的帮助和参考。方法 检索关于卒中后睡眠障碍中医护理研究的文献, 主要检索的关键词包括脑卒中、卒中后睡眠障碍、睡眠障碍、中医护理、中医护理技术等, 检索数据库选择中国知网(CNKI)、万方(Wanfang Data)、维普(VIP)以及中国生物医学文献数据库(CBM), 时间截止到2023年1月31日, 使用CiteSpace软件进行分析, 主要包括年发文量、作者、研究机构、关键词共现、聚类、时间线等。结果 通过检索, 共计有177篇文献符合本次研究需求; 经过分析发现, 相关文献资料呈上升趋势, 逐年增加; 在研究中能看到相关的研究者和研究机构之间尚未形成成熟的合作关系网络; 同时, 卒中后睡眠障碍在中医研究中, 主要的研究焦点在于延续护理、情志护理以及中医护理技术等。结论 通过对相关文献的分析和整理发现, 针对卒中后睡眠障碍, 中医护理干预能够显著改善患者睡眠质量, 促进患者病情的改善和生活质量的提升, 在临床使用中有着非常理想的效果。)

Objective To systematically evaluate the efficacy of acupoint application in the treatment of post-stroke dysphagia. Methods PubMed, Embase, the Cochrane Library, Web of Science, CNKI, VIP, Wanfang databases and CMB were searched for studies on acupoint application in the treatment of post-stroke dysphagia. The search time limit was from the establishment of the database to January 31, 2023. Two researchers independently screened the literature, extracted data and evaluated the methodological quality. RevMan 5. 4 software was used for meta-analysis. Results A total of 11 RCTS/CCTS involving 1018 patients were included. Acupoint application in the treatment of dysphagia after stroke was superior to the control group in the total effective rat［OR=4. 16, 95% CI(2. 65, 6. 53), Z=6. 21(P＜0. 01)］, cure rate［OR=1. 76, 95% CI(1. 30, 2. 39), Z=3. 66(P＜0. 01)］, Kubota drinking test score［MD=－1. 05, 95% CI(－1. 69, －0. 41), Z=3. 20(P＜0. 01)］, Ichiro Fujima swallowing efficacy score［MD=2. 73, 95% CI(1. 73, 3. 74), Z=5. 31(P＜0. 01)］, VFSS score［MD=1. 81, 95% CI(1. 57, 2. 05), Z=14. 75(P＜0. 01)］, prealbumin［MD=22. 10, 95% CI(10. 65, 33. 54), Z=3. 78(P＜0. 01)］, serum albumin［MD=4. 08, 95% CI(1. 99, 6. 18), Z=3. 82(P＜0. 01)］ and NRS2002 score［MD=－0. 28, 95% CI(－0. 42, －0. 14), Z=3. 85(P＜0. 01)］. Conclusion Acupoint application is effective and reliable in the treatment of dysphagia after stroke, which can be used for clinical promotion. However, the quality and quantity of the literature included in the analysis are limited, and high-quality, large-sample double-blind randomized controlled trials are still needed to provide higher level of evidence. (目的 系统评价穴位敷贴治疗卒中后吞咽障碍的疗效。方法 计算机检Cochrane Library、Web of Science、PubMed、Embase、中国知网(CNKI)、维普数据库(VIP)、万方数据库(Wanfang Data)、中国生物医学文献数据库(CMB)中关于穴位敷贴治疗卒中后吞咽障碍的研究, 检索时限均为数据库建立至2023年1月31日。由两名研究员独立进行文献筛选、数据提取及方法学质量评价后, 采用RevMan 5. 4软件对纳入研究进行Meta分析。结果 共纳入11项RCT/CCT研究, 1018例患者。 Meta分析结果显示, 穴位贴敷治疗脑卒中后吞咽障碍在总有效率［OR=4. 16, 95% CI(2. 65, 6. 53), Z=6. 21(P＜0. 01)］、痊愈率［OR=1. 76, 95% CI(1. 30, 2. 39), Z=3. 66(P＜0. 01)］、洼田饮水试验评分［MD=－1. 05, 95% CI(－1. 69, －0. 41), Z=3. 20(P=0. 001)］、藤岛一郎吞咽疗效评分［MD=2. 73, 95% CI(1. 73, 3. 74), Z=5. 31(P＜0. 01)］、VFSS评分［MD=1. 81, 95% CI(1. 57, 2. 05), Z=14. 75(P＜0. 01)］、前白蛋白［MD=22. 10, 95% CI(10. 65, 33. 54), Z=3. 78(P＜0. 01)］、血清白蛋白［MD=4. 08, 95% CI(1. 99, 6. 18) , Z=3. 82(P＜0. 01)］、NRS2002评分［MD=－0. 28, 95% CI(－0. 42, －0. 14) , Z=3. 85(P＜0. 01)］方面优于对照组。结论 穴位贴敷治疗脑卒中后吞咽困难的疗效可靠, 可用于临床推广。但纳入分析的文献质量和数量有限, 仍需高质量、大样本的双盲随机对照试验提供更高级别的证据。)